Nanobiotix Appoints Arnd Christ as Chief Financial Officer
PRIVATEOct 01, 2026
Position
Chief Financial Officer
Company
Nanobiotix S.A
Arnd Christ
BiotechnologyHealth Care
Description
Nanobiotix has announced the appointment of Arnd Christ as Chief Financial Officer, effective October 1, 2026. He succeeds Bart Van Rhijn, who is stepping down after five years of service.
Company Information
Company
Nanobiotix S.A
About
NANOBIOTIX is a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer and other major diseases. The company is focused on advancing innovative therapies through scientific research and development. NANOBIOTIX operates in the biotech sector, particularly in oncology. It is listed on Euronext and NASDAQ.
Fundz sees it the moment Nanobiotix S.A changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.